Michael Burry leans into a Molina Healthcare rebound while maintaining bearish bets on Nvidia and Palantir

Michael Burry, the investor made famous by The Big Short, is reportedly reshaping his bets in several high-profile stocks tied to the AI boom and to U.S. healthcare. A report from Yahoo Finance on Aug. 12 said Burry added to positions involving Nvidia and Palantir while also increasing exposure to Molina Healthcare. The article also highlighted that Molina is down about 54% from its high, a decline the report frames as part of the appeal of the move.

Nvidia is widely viewed as the critical hardware supplier powering much of the AI buildout, from data-center training to inference. Palantir, by contrast, is a software and data analytics company whose products are often discussed in the context of government and commercial use cases involving data integration, operational analytics, and (in recent years) AI-related deployment patterns. The Yahoo report does not provide additional detail in its headline and description about why Burry chose to add to shorts in those two companies, or about what specifically he expects to go wrong for them. It also does not disclose whether those bets reflect changes in timing, valuation concerns, or fundamental deterioration.

For Molina Healthcare, the reported move is described as a “loading up” phase by Burry, paired with the sharp drawdown referenced in the report. Molina Healthcare focuses on Medicaid and other government-sponsored programs in the U.S., making it highly sensitive to reimbursement levels, enrollment trends, and the regulatory environment around managed care. The Yahoo Finance piece frames Burry’s increased interest as a contrarian stance toward a stock that has already sold off substantially from its peak, implying that the market’s pessimism may be more severe than the business fundamentals suggest.

The report also indicates that Burry’s portfolio actions are not simply a blanket “bullish AI” or “bearish AI” thesis. Instead, it suggests a more selective approach, with bearish exposure to two prominent AI-linked equities and bullish exposure to a healthcare payer that is tied to different drivers altogether. Without additional disclosure details, it is not possible to determine whether Burry’s Palantir and Nvidia shorts are concentrated in the near term or whether they reflect longer-term expectations about competitive positioning, demand durability, or margins.

Sector context matters because Palantir and Nvidia are both closely associated with the modern wave of data and AI spending, but they sit at different points in the supply chain. Nvidia benefits from the demand for computing infrastructure, while Palantir’s narrative centers on applying software and data platforms to complex workflows. When investors turn cautious about the AI spending cycle, the impact can be felt unevenly across the ecosystem. Molina Healthcare, meanwhile, is driven less by AI sentiment and more by policy and care delivery outcomes. That separation can make it easier for an investor like Burry to express a valuation or risk-reward view in one area without needing to make the same call in another.

One limitation of the information provided in the Yahoo Finance alert is that it does not include the size of the changes, the exact instruments used, or whether the “shorts” are executed through typical short-selling, derivatives, or other vehicles. It also does not describe any specific catalysts or events that Burry is responding to in Nvidia or Palantir. As with many portfolio headlines, readers should treat the report as a snapshot of positioning rather than a full explanation of the underlying thesis until additional filing-level detail is available.

Going forward, what to watch most closely is whether Burry’s reported adjustments line up with subsequent regulatory disclosures and whether the companies he is betting against show signs of the issues the shorts imply. For Molina, investors will likely look for evidence that the business can stabilize and recover from the factors behind its sharp decline from the high. In the near term, market attention may also turn to broader AI spending expectations, because Nvidia and Palantir are often discussed as proxies for the health of that cycle even when their fundamental drivers differ.